Soft -adrenergic agonists for the topical treatment of psoriasis

Author： Gill H. Freeman S. Irwin W. Wilson K.

Publisher： Elsevier

ISSN： 0223-5234

Source： European Journal of Medicinal Chemistry, Vol.31, Iss.11, 1996-01, pp. : 847-859

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Topical treatment of psoriasis

By Laws Philip M Young Helen S

Expert Opinion on Pharmacotherapy, Vol. 11, Iss. 12, 2010-08 ,pp. : 1999-2009

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenetics of topical and systemic treatment of psoriasis

By Prieto-Pérez Rocío Cabaleiro Teresa Daudén Esteban Ochoa Dolores Román Manuel Abad-Santos Francisco

Pharmacogenomics, Vol. 14, Iss. 13, 2013-10 ,pp. : 1623-1634

Future Medicine

Access to resources Recommend Favorite

Topical becocalcidiol has shown promise in the treatment of patients with chronic plaque psoriasis

Inpharma, Vol. 1, Iss. 1606, 2007-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Clinical Pharmacokinetics and Drug Metabolism of Tazarotene: A Novel Topical Treatment for Acne and Psoriasis

By Tang-Liu D.-S. Matsumoto R.M. Usansky J.I.

Clinical Pharmacokinetics, Vol. 37, Iss. 4, 1999-10 ,pp. : 273-287

Adis International

Access to resources Recommend Favorite

₂-Adrenergic agonists as analgesic agents

By Boyd R.E.

Expert Opinion on Therapeutic Patents, Vol. 10, Iss. 11, 2000-11 ,pp. : 1741-1748

Informa Healthcare

Access to resources Recommend Favorite